The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.
LTC pharmacies pivot after feds call for timeout on J&J COVID vaccine
By
Danielle Brown
Apr 14, 2021
Long-term care pharmacies have stopped using the Johnson & Johnson COVID-19 vaccine and are awaiting further instruction from federal health officials, who recommended the halt while they investigate six...
Good news for (yawn) shift workers and residents
By
Tim Mullaney
Aug 19, 2014
Long-term care professionals around the country cheered wildly last week when the Food and Drug Administration approved Belsomra, a new sleep drug. Shift workers applauded the addition to their medicine...
Study questions fish oil claims, popularity
By
Kristen Fischer
Aug 24, 2023
One in every five adults aged more than 60 years takes fish oil supplements, despite many warnings that they have no benefit for heart health. A new study sheds light on what the product labels say that...
FDA set to approve two COVID-19 antiviral pills this week
By
Alicia Lasek
Dec 22, 2021
FDA is expected to grant emergency use authorization to two antiviral COVID-19 pills this week, possibly as early as today, according to Bloomberg News, citing sources familiar with the matter.
Implant provides hope for the limping
By
Elizabeth Newman
Jul 29, 2016
In one of the sadder coincidences of my life, news of an FDA-approved cartilage implant made me more excited than it would have a year ago. That’s because this particular synthetic cartilage implant...
FDA no longer requires positive COVID-19 test to prescribe Paxlovid, Lagevrio
By
Alicia Lasek
Feb 01, 2023
The FDA on Wednesday made it easier for clinicians to prescribe these antiviral drugs in cases where transmission is evident and the patient is at high risk of severe illness.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
U.S. COVID-19 strategy must veer to protecting the vulnerable, experts say
By
Alicia Lasek
Mar 22, 2022
When planning for a future with COVID-19, some clinicians believe that the public health focus should turn from stopping transmission to protecting those most likely to become severely ill, according to...
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.